Company BIONET Corp.

Equities

1784

TW0001784007

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
65.9 ^TWD	+0.61%		-1.20%	+13.43%

Mar. 19	BIONET Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	BIONET Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

BIONET CORP. is a Taiwan-based company principally engaged in the storage and application of hematopoietic stem cells. The Companyâs main products include umbilical cord blood stem cells, mesenchymal stem cells, adult peripheral blood stem cells and others. The Company also provides precision medical application, prenatal testing and genetic testing services. The Company operates its businesses mainly in domestic market.

TWD in Million	2022	Weight	2023	Weight	Delta
Stem Cell-related Products and Gene Testing 90.3 %	884	90.1 %	1,018	90.3 %	+15.19%
Other 9.7 %	97	9.9 %	109	9.7 %	+13.10%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 98.5 %	960	98.0 %	1,110	98.5 %	+15.57%
Others 1.5 %	20	2.0 %	17	1.5 %	-12.96%

Managers	Title	Age	Since
Tien Lai Liu CEO	Chief Executive Officer	-	06-08-31
Pei Yi Liu DFI	Director of Finance/CFO	-	18-03-22

Members of the board	Title	Age	Since
Shao Hua Huang BRD	Director/Board Member	75	06-11-20
Cheng Hsien Tsai CHM	Chairman	-	00-07-31
Wen Cheng Chang BRD	Director/Board Member	-	03-04-10
Wen Hsi Yan BRD	Director/Board Member	-	06-06-27
Pao Hsi Sheng BRD	Director/Board Member	-	19-06-26
Shih Ming Liang BRD	Director/Board Member	-	07-10-25
Han Tung Chang BRD	Director/Board Member	-	06-06-27

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	49,627,000	35,044,924 ( 70.62 %)	2,330,000 ( 4.695 %)	70.62 %

Name	Equities	%	Valuation
DFA Australia Ltd. 0.000330 %	164	0.000330 %	323 NT$

Bionet Corp.

1F No.28, 36 Lane, Xinhu 1st Road

114 97, Taipei

http://www.babybanks.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
BIONET CORP.	+13.43%	95.54M
MODERNA, INC.	+28.45%	48.16B
IQVIA HOLDINGS INC.	-1.08%	41.73B
LONZA GROUP AG	+43.45%	41.03B
CELLTRION, INC.	-5.26%	28.77B
ICON PUBLIC LIMITED COMPANY	+10.12%	25.59B
ALNYLAM PHARMACEUTICALS, INC.	-22.94%	18.96B
BIO-TECHNE CORPORATION	+8.01%	12.92B
MEDPACE HOLDINGS, INC.	+29.01%	12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.90%	11.77B

Other Biotechnology & Medical Research